HIRABA

Description

Hiraba is a supplement containing Ademetionine (S-Adenosyl L-Methionine) 400 mg, designed as a comprehensive solution for liver and neurological health. As a systematic hepatoprotector, it helps regulate the synthesis of the antioxidant glutathione, supports liver detoxification, acts as a methylating agent, and reduces oxidative metabolic stress. These actions make it beneficial for conditions such as alcoholic liver disease, hepatotoxicity, cholestasis, viral hepatitis, and non-alcoholic fatty liver disease. In addition, Hiraba provides supreme care for neurological disorders by restoring methyl group metabolism, normalizing blood homocysteine levels, and replenishing neurotransmitters like dopamine, serotonin, and norepinephrine. It acts as a mood-elevation agent with a rapid onset, making it suitable for managing Alzheimer’s disease, dementia, cognitive dysfunction, Parkinson’s disease, and depression. Overall, Hiraba is presented as a safe, effective, and well-tolerated product for promoting both liver and brain health.

Key Benefits

Hepatoprotector (Liver Protection)

• Regulates glutathione synthesis: Enhances production of a powerful antioxidant in the body.

• Supports liver detoxification: Plays a vital role in neutralizing toxins.

• Acts as a methylating agent: Helps liver functions that require methylation.

• Inhibits oxidative metabolic activity: Reduces oxidative stress in liver tissue.

Indications for Liver Use:

• Alcoholic liver disease

• Hepatotoxicity

• Cholestasis

• Viral hepatitis

• Non-alcoholic fatty liver disease

Neurological Support

• Restores methyl metabolism: Normalizes blood homocysteine levels.

• Safe, effective, and well tolerated.

• Restores neurotransmitter levels: Helps replenish dopamine, serotonin, and norepinephrine, which are important for brain function and mood.

• Acts as a mood-elevation agent: May have a quick effect on mood enhancement.

Indications for Neurological Disorders:

• Alzheimer’s disease

• Dementia

• Cognitive dysfunction

• Parkinson’s disease

• Depression